Shelling AN - Search Results

1

Nanoparticulate carriers: an emerging tool for breast cancer therapy.

Tharkar P, Madani AU, Lasham A, Shelling AN, Al-Kassas R. Tharkar P, et al. Among authors: shelling an. J Drug Target. 2015 Feb;23(2):97-108. doi: 10.3109/1061186X.2014.958844. Epub 2014 Sep 18. J Drug Target. 2015. PMID: 25230853 Review.

2

Predictive and prognostic molecular markers for cancer medicine.

Mehta S, Shelling A, Muthukaruppan A, Lasham A, Blenkiron C, Laking G, Print C. Mehta S, et al. Ther Adv Med Oncol. 2010 Mar;2(2):125-48. doi: 10.1177/1758834009360519. Ther Adv Med Oncol. 2010. PMID: 21789130 Free PMC article.

3

Nanocarrier systems for delivery of siRNA to ovarian cancer tissues.

Fathabadi EG, Shelling AN, Al-Kassas R. Fathabadi EG, et al. Among authors: shelling an. Expert Opin Drug Deliv. 2012 Jul;9(7):743-54. doi: 10.1517/17425247.2012.683173. Epub 2012 Jun 4. Expert Opin Drug Deliv. 2012. PMID: 22657869 Review.

4

Nanoparticle therapeutics: Technologies and methods for overcoming cancer.

Cerqueira BB, Lasham A, Shelling AN, Al-Kassas R. Cerqueira BB, et al. Among authors: shelling an. Eur J Pharm Biopharm. 2015 Nov;97(Pt A):140-51. doi: 10.1016/j.ejpb.2015.10.007. Epub 2015 Oct 26. Eur J Pharm Biopharm. 2015. PMID: 26515260 Review.

5

A novel EGR-1 dependent mechanism for YB-1 modulation of paclitaxel response in a triple negative breast cancer cell line.

Lasham A, Mehta SY, Fitzgerald SJ, Woolley AG, Hearn JI, Hurley DG, Ruza I, Algie M, Shelling AN, Braithwaite AW, Print CG. Lasham A, et al. Among authors: shelling an. Int J Cancer. 2016 Sep 1;139(5):1157-70. doi: 10.1002/ijc.30137. Epub 2016 May 26. Int J Cancer. 2016. PMID: 27072400

6

Development of biodegradable PLGA nanoparticles surface engineered with hyaluronic acid for targeted delivery of paclitaxel to triple negative breast cancer cells.

Cerqueira BBS, Lasham A, Shelling AN, Al-Kassas R. Cerqueira BBS, et al. Among authors: shelling an. Mater Sci Eng C Mater Biol Appl. 2017 Jul 1;76:593-600. doi: 10.1016/j.msec.2017.03.121. Epub 2017 Mar 18. Mater Sci Eng C Mater Biol Appl. 2017. PMID: 28482569

7

Gene expression profiling of breast tumours from New Zealand patients.

Muthukaruppan A, Lasham A, Blenkiron C, Woad KJ, Black MA, Knowlton N, McCarthy N, Findlay MP, Print CG, Shelling AN. Muthukaruppan A, et al. Among authors: shelling an. N Z Med J. 2017 Oct 27;130(1464):40-56. N Z Med J. 2017. PMID: 29073656

8

A Predictor of Early Disease Recurrence in Patients With Breast Cancer Using a Cell-free RNA and Protein Liquid Biopsy.

Lasham A, Fitzgerald SJ, Knowlton N, Robb T, Tsai P, Black MA, Williams L, Mehta SY, Harris G, Shelling AN, Blenkiron C, Print CG. Lasham A, et al. Among authors: shelling an. Clin Breast Cancer. 2020 Apr;20(2):108-116. doi: 10.1016/j.clbc.2019.07.003. Epub 2019 Aug 22. Clin Breast Cancer. 2020. PMID: 31607655

9

YB-1, the E2F pathway, and regulation of tumor cell growth.

Lasham A, Samuel W, Cao H, Patel R, Mehta R, Stern JL, Reid G, Woolley AG, Miller LD, Black MA, Shelling AN, Print CG, Braithwaite AW. Lasham A, et al. Among authors: shelling an. J Natl Cancer Inst. 2012 Jan 18;104(2):133-46. doi: 10.1093/jnci/djr512. Epub 2011 Dec 28. J Natl Cancer Inst. 2012. PMID: 22205655 Free PMC article.

10

Multimodal Assessment of Estrogen Receptor mRNA Profiles to Quantify Estrogen Pathway Activity in Breast Tumors.

Muthukaruppan A, Lasham A, Woad KJ, Black MA, Blenkiron C, Miller LD, Harris G, McCarthy N, Findlay MP, Shelling AN, Print CG. Muthukaruppan A, et al. Among authors: shelling an. Clin Breast Cancer. 2017 Apr;17(2):139-153. doi: 10.1016/j.clbc.2016.09.001. Epub 2016 Sep 13. Clin Breast Cancer. 2017. PMID: 27756582 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

146 results

Search Page

Filters